- Udyam number
- UDYAM-GJ-01-0037391

About Alvita Pharma Private Limited
Data last updated:
Alvita Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PTC059305. Its GSTIN is 24AAICA1744Q2ZD (Gujarat). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9 Cr. It is led by directors including Manoj Ramaniklal Vora and Surendra Kumar Lohia.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B 203 Gopal Palace Near Nehru Nagar Circle Satellite Road Ambavadi, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2024, the company reported a revenue of ₹119.83 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹24.12 Cr (net margin 20.1%) and EBITDA of ₹33.46 Cr (EBITDA margin 27.9%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 29% over five years.
The company has about 72 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Alvita. As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹59.65 Cr on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it; 2 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2024. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Shine Pharmaceuticals Limited with revenue of ₹120.09 Cr. The company has 8 MSME Form 1 returns on record between 2018 and 2022, listing 275 overdue payments to 47 micro and small suppliers.
Alvita Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0037391). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alvitapharma.co.in.
Company details
Recognitions & Rankings of Alvita Pharma
Contact details
Alvita Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is alvitapharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB 203 Gopal Palace Near Nehru Nagar Circle Satellite Road Ambavadi, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alvita Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Alvita Pharma operates one associated brand: ALVITA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical research, development, quality assurance, and global business services by ALVITA. | alvitapharma.co.in |
Business activity
The main business activity of Alvita Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Alvita Pharma Private Limited, buy the company report.
Financials of Alvita Pharma Private Limited
FY 2024 filings availableAlvita Pharma Private Limited reported revenue of ₹119.83 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 7% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.46 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24.12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27.9% | ||||
| Net Profit Margin | 20.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alvita Pharma Private Limited, buy the company report.
Board of directors of Alvita Pharma Private Limited
Alvita Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Ramaniklal Vora Also directs: Novagen Healthcare Private Limited, Alvita Foundation | Director | 14 Jul 2010 | 16 Years 4 Months | Current |
| Surendra Kumar Lohia | Director | 02 Feb 2015 | 11 Years 9 Months | Current |
| Sajan Parmeswaran Unnithan | Director | 16 Sep 2010 | 16 Years 2 Months | Current |
Peer comparison
Alvita Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shine Pharmaceuticals Limited | ₹120.09 Cr (FY 2025) | -4.0% | Vadodara, Gujarat, India | |||
| Ananta Medicare Limited | ₹120.04 Cr (FY 2025) | 50.0% | Delhi, India | |||
| Amol Pharmaceuticals Private Limited | ₹119.9 Cr (FY 2025) | 5.0% | Jaipur, Rajasthan, India | |||
| Alvita Pharma Private Limitedthis company | ₹119.83 Cr (FY 2024) | ₹24.12 Cr | 20.1% | 7.0% | 72 | Ahmedabad, Gujarat, India |
| M J Biopharm Private Limited | ₹119.1 Cr (FY 2017) | 9.0% | Mumbai, Maharashtra, India | |||
| Pell Tech Health Care Private Limited | ₹118.72 Cr (FY 2025) | 16.0% | Thane, Maharashtra, India | |||
| Ronak Healthcare Private Limited | ₹118.43 Cr (FY 2025) | 79.0% | Vadodara, Gujarat, India | |||
| Zen Pharma Private Limited | ₹118.25 Cr (FY 2022) | 24.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Alvita Pharma Private Limited, buy the company report.
Auditor
Alvita Pharma Private Limited is audited by Jinesh R. Bhagdev & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Jinesh R. Bhagdev & Co. | FY 2022 | 143988W |
Shareholding
The shareholding of Alvita Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Alvita Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Jan 2013 | 10405597 | Others | ₹6 Cr | Open | |
| 10 Dec 2020 | 100414441 | Hdfc Bank Limited | ₹30.51 Cr | Satisfied | |
| 26 Jul 2017 | 100121805 | Indian Bank | ₹27.7 Cr | Satisfied | |
| 23 Jan 2015 | 10544639 | Kotak Mahindra Bank Limited | ₹1.44 Cr | Satisfied |
To see the full charge records of Alvita Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Alvita Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2024.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2024 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2020 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Dec 2012 | Funding round | ₹9 Lakh | Investors: 2 individuals |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Alvita Pharma Private Limited has 6 court cases on record: 4 filed by Alvita Pharma, 2 filed against it. 2 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 2 | 2 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed by the company against individuals | Pending |
| District court, Gurugram, Haryana | Civil suit | Filed against the company by M/S Lek Laboratories | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed by the company against Bhavesh Gordhanbhai Sutariya Prop of Photon Pharma | Disposed |
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company by an individual | Disposed |
| District court, Thane, Maharashtra | Criminal miscellaneous application | Filed by the company against State of Maharashtra -Through the Druge Inspector Shri. K.G. Gadewar. | Disposed |
To see the full case history of Alvita Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Alvita Pharma Private Limited was last rated by Crisil on 15 Mar 2018.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Mar 2018 |
To see the full credit ratings and regulatory alerts of Alvita Pharma Private Limited, buy the company report.
MSME payment delays
Alvita Pharma Private Limited has 8 MSME Form 1 returns on record between 2018 and 2022, listing 275 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 47)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Pavesha Pharma Pack | |||
| Zen Scientific Private Limited | |||
| an individual supplier | |||
| Siddhi Packaging Private Limited |
To see the full MSME payment records of Alvita Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Alvita Pharma Private Limited has a workforce of 72 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 72 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Alvita Pharma Private Limited, buy the company report.
GST
Alvita Pharma has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICA1744Q2ZD | Gujarat | Active | 01 Jul 2017 |
| 27AAICA1744Q1Z8 | Maharashtra | Active | 17 Aug 2017 |
| 27AAICA1744Q2Z7 | Maharashtra | Active | 01 Mar 2021 |
To see the full GST registrations and return filing status of Alvita Pharma Private Limited, buy the company report.
Recent activity
Alvita Pharma Private Limited has 8 board changes on record since 2010: 3 appointments and 5 cessations. The latest: Surendra Kumar Lohia ceased to be Additional Director on 30 Sep 2015.
7 earlier events are in the company report.
Frequently asked questions
Alvita Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2010 (16+ years old) and is registered under CIN U24230GJ2010PTC059305.
Alvita Pharma has 3 current directors:
- Manoj Ramaniklal Vora - Director
- Surendra Kumar Lohia - Director
- Sajan Parmeswaran Unnithan - Director
The latest financial statements of Alvita Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Alvita Pharma is 24AAICA1744Q2ZD, registered in Gujarat. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAICA1744Q1Z8 (Maharashtra), 27AAICA1744Q2Z7 (Maharashtra).
The CIN (Corporate Identification Number) of Alvita Pharma is U24230GJ2010PTC059305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alvita Pharma has 6 court cases on record: 4 filed by the company and 2 filed against it. 2 are pending.
Alvita Pharma was incorporated on 23 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Alvita Pharma has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2024.
The peers of Alvita Pharma by revenue are Shine Pharmaceuticals Limited, Ananta Medicare Limited, Amol Pharmaceuticals Private Limited, M J Biopharm Private Limited, Pell Tech Health Care Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Surendra Kumar Lohia ceased to be Additional Director on 30 Sep 2015. Surendra Kumar Lohia was appointed as Director on 02 Feb 2015. Manoj Ramaniklal Vora ceased to be Additional Director on 18 Jul 2011. Alvita Pharma has 8 board changes on record in total.
Yes, Alvita Pharma is registered as an MSME under Udyam registration (number: UDYAM-GJ-01-0037391).
Alvita Pharma has 8 MSME Form 1 returns on record between 2018 and 2022, listing 275 overdue payments to 47 micro and small suppliers. The latest return was filed on 31 May 2022.

